WINDSOR HOUSE GROUP PRACTICE — All Prescriptions & Medications — Page 3
Practice Code: B86057 | LEEDS, LS27 9NB
Showing results 101-150 of 751
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Mesalazine (Systemic) | 801 | 85.3K | £37.8K | +234.4% ▲ |
| Fluticasone furoate | 800 | 845 | £6.1K | +313.0% ▲ |
| Sumatriptan succinate | 781 | 8,130 | £13.7K | +120.5% ▲ |
| Loratadine | 779 | 33.9K | £819 | +272.8% ▲ |
| Latanoprost | 764 | 11.9K | £4.6K | +57.4% ▲ |
| Mometasone furoate | 758 | 857 | £6.7K | +88.8% ▲ |
| Duloxetine hydrochloride | 754 | 21.5K | £1.7K | +18.6% ▲ |
| Phenoxymethylpenicillin (Penicillin V) | 749 | 66.7K | £2.5K | +144.4% ▲ |
| Estradiol with progestogen | 743 | 21.5K | £25.4K | +118.0% ▲ |
| Zopiclone | 738 | 9,546 | £430 | +33.3% ▲ |
| Fluticasone/umeclidinium/vilanterol | 727 | 822 | £34.8K | +210.1% ▲ |
| Felodipine | 726 | 24.1K | £4.1K | +22.3% ▲ |
| Desogestrel | 726 | 195.1K | £5.8K | +83.1% ▲ |
| Memantine hydrochloride | 718 | 13.2K | £3.6K | +117.4% ▲ |
| Enalapril maleate | 707 | 28.2K | £954 | +293.5% ▲ |
| Mebeverine hydrochloride | 706 | 56.1K | £2.2K | +127.4% ▲ |
| Empagliflozin | 706 | 22.1K | £27.5K | +12.8% ▲ |
| Budesonide | 702 | 880 | £20.3K | +29.5% ▲ |
| Lithium carbonate | 699 | 15.2K | £2.8K | +451.0% ▲ |
| Glyceryl trinitrate | 682 | 3,439 | £2.0K | +188.3% ▲ |
| Bumetanide | 671 | 26.6K | £2.6K | +146.3% ▲ |
| Hydroxocobalamin | 669 | 805 | £1.8K | +39.0% ▲ |
| Diazepam | 666 | 14.9K | £519 | +33.7% ▲ |
| 665 | 682 | £961 | +201.8% ▲ | |
| Sitagliptin | 656 | 20.3K | £1.5K | +68.2% ▲ |
| Carbamazepine | 653 | 49.6K | £4.2K | +120.0% ▲ |
| Pantoprazole | 652 | 21.3K | £992 | +137.2% ▲ |
| Estriol | 649 | 11.2K | £5.6K | +205.0% ▲ |
| Loperamide hydrochloride | 632 | 52.4K | £1.9K | +171.4% ▲ |
| Fluticasone propionate (Inhalation) | 623 | 744 | £16.5K | +61.0% ▲ |
| Other multivitamin preparations | 614 | 18.1K | £5.7K | +255.3% ▲ |
| Fluticasone furoate/vilanterol | 607 | 734 | £16.8K | +292.1% ▲ |
| Paroxetine hydrochloride | 600 | 17.7K | £1.1K | +221.5% ▲ |
| Insulin aspart | 584 | 4,014 | £30.4K | +53.4% ▲ |
| Oxybutynin | 568 | 33.6K | £12.1K | +198.2% ▲ |
| Sodium valproate | 560 | 92.1K | £8.1K | +76.1% ▲ |
| Risperidone | 551 | 12.6K | £1.2K | +117.8% ▲ |
| Beclometasone dipropionate | 547 | 566 | £1.7K | +154.3% ▲ |
| Olanzapine | 541 | 11.3K | £1.2K | +46.0% ▲ |
| Quetiapine | 537 | 22.2K | £10.1K | -13.7% ▼ |
| Oxycodone hydrochloride | 527 | 36.5K | £13.4K | +105.9% ▲ |
| Co-careldopa (Carbidopa/levodopa) | 523 | 50.1K | £3.6K | +131.4% ▲ |
| Insulin glargine | 523 | 3,280 | £25.0K | +84.2% ▲ |
| Clarithromycin | 520 | 12.7K | £2.4K | +111.9% ▲ |
| Docusate sodium | 519 | 61.6K | £4.8K | +40.0% ▲ |
| 510 | 542 | £3.1K | +115.9% ▲ | |
| 498 | 4,480 | £1.5K | +138.3% ▲ | |
| Dexamethasone | 495 | 2,515 | £1.6K | +187.9% ▲ |
| 477 | 4,439 | £1.7K | +91.2% ▲ | |
| Hyoscine butylbromide | 461 | 43.1K | £3.2K | +97.8% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.